Dr. Parsley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
2280
Houston, TX 77030Phone+1 713-795-5155Fax+1 713-795-5515
Education & Training
University of Texas Health Science Center at HoustonFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
Oklahoma State University Center for Health SciencesClass of 1988
Certifications & Licensure
CA State License 2016 - 2025
OK State License 1984 - 2023
TX State License 1992 - 2018
Clinical Trials
- Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer Start of enrollment: 2016 Jan 01
Publications & Presentations
PubMed
- 89 citationsBronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung DiseaseCharlie Strange, Marcy B. Bolster, Michael D. Roth, Richard M. Silver, Arthur C. Theodore
American Journal of Respiratory and Critical Care Medicine. 2008-01-01 - 297 citationsEffects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.Donald P. Tashkin, Robert Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst
American Journal of Respiratory and Critical Care Medicine. 2007-11-15 - 70 citationsImpact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.Dinesh Khanna, Xiaohong Yan, Donald P. Tashkin, Daniel E. Furst, Robert Elashoff
Arthritis and Rheumatism. 2007-05-01
Press Mentions
Mast Therapeutics Initiates Phase 2 Study of Vepoloxamer for the Treatment of Chronic Heart FailureOctober 26th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
